Aberrant cAMP Metabolism in NF1 Malignant Peripheral Nerve Sheath Tumor Cells

被引:13
作者
Dang, Ian [2 ,3 ]
De Vries, George H. [1 ,4 ]
机构
[1] McGuire VA Med Ctr, Richmond, VA 23249 USA
[2] Hines VA Hosp, Hines, IL 60141 USA
[3] Loyola Univ, Dept Cell Biol Neurobiol & Anat, Med Ctr, Maywood, IL 60153 USA
[4] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA
关键词
cAMP; Neurofibromatosis type I; Schwann cells; MPNST cell lines; Normal human Schwann cells; Prostaglandin metabolism; CYCLIC-AMP; SCHWANN-CELLS; ADENYLYL-CYCLASE; MAST-CELLS; PHOSPHORYLATION; NEUROFIBROMIN; RECEPTORS; INDUCTION; CYTOKINES; RESPONSES;
D O I
10.1007/s11064-011-0433-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Malignant peripheral nerve sheath (MPNST) cell lines derived from patients with neurofibromatosis type 1 (NF!) were found to have basal cAMP levels which are two-fold higher than cAMP levels in normal human adult Schwann cells (nHSC). PCR analysis also revealed that normal adult human Schwann cells express mRNA for types Ill, IV, and IX adenylyl cyclase (AC) while NF1 MPNST cells express AC mRNA of types II, V, and VIII in addition to expressing all the isoforms of normal adult human Schwann cells. Further PCR analysis revealed that NF1 MPNST lines express mRNA for EP2 and EP4 prostaglandin receptors whereas nHSC only express mRNA for the EP2 receptor. Exogenous prostaglandins alone or in combination with PDGF BB induced greater increases in cAMP levels and proliferation of NF1 MPNST cells compared to nHSC. We conclude that aberrant cAMP signaling in NF1 MPNST cells contributes to tumor formation in NF1 patients.
引用
收藏
页码:1697 / 1705
页数:9
相关论文
共 44 条
[1]
Badache A, 1998, J CELL PHYSIOL, V177, P334, DOI 10.1002/(SICI)1097-4652(199811)177:2<334::AID-JCP15>3.0.CO
[2]
2-9
[3]
ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS [J].
BASU, TN ;
GUTMANN, DH ;
FLETCHER, JA ;
GLOVER, TW ;
COLLINS, FS ;
DOWNWARD, J .
NATURE, 1992, 356 (6371) :713-715
[4]
Casella GTB, 2000, GLIA, V30, P165, DOI 10.1002/(SICI)1098-1136(200004)30:2<165::AID-GLIA6>3.0.CO
[5]
2-L
[6]
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[7]
Quantitation of changes in P0 mRNA by polymerase chain reaction in primary cultured Schwann cells stimulated by axolemma-enriched fraction [J].
Clive, DR ;
Lopez, TJ ;
DeVries, GH .
JOURNAL OF NEUROSCIENCE METHODS, 1998, 81 (1-2) :25-34
[8]
COLEMAN RA, 1994, PHARMACOL REV, V46, P205
[9]
PRODUCTION OF PROSTANOIDS BY LEWIS RAT SCHWANN-CELLS IN-VITRO [J].
CONSTABLE, AL ;
ARMATI, PJ ;
TOYKA, KV ;
HARTUNG, HP .
BRAIN RESEARCH, 1994, 635 (1-2) :75-80
[10]
Glial Cell Lines: An Overview [J].
De Vries, George H. ;
Boullerne, Anne I. .
NEUROCHEMICAL RESEARCH, 2010, 35 (12) :1978-2000